Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128641) titled 'Odronextamab in Low Tumor Volume Advanced FL' on Aug. 14.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Gottfried von Keudell, MD PhD
Condition:
Follicular Lymphoma
Lymphoma
Intervention:
Biological: Odronextamab
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: October 2025
Target Sample Size: 35
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07128641
Published by HT Digital Content Services wit...